Literature DB >> 9986825

Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children.

P Toikka1, S Nikkari, O Ruuskanen, M Leinonen, J Mertsola.   

Abstract

Blood-based pneumolysin PCR was compared to blood culture and detection of pneumolysin immune complexes, as well as to detection of antibodies to pneumolysin and to C polysaccharide, in the diagnosis of pneumococcal infection in 75 febrile children. Invasive pneumococcal infection was suspected on clinical grounds in 67 of the febrile children, and viral infection was suspected on clinical grounds in 8 of the febrile children. In addition, 15 healthy persons were examined to test the specificity of the PCR assay. Plasma, serum, and leukocyte fractions were analyzed by PCR. The combination of all test results led to the diagnosis of pneumococcal infection in 25 patients. Pneumolysin PCR was positive in 44% of these children, an increase occurred in the pneumolysin antibodies in 39% and in the C polysaccharide antibodies in 30% of the patients; pneumolysin immune complexes were found in convalescent serum in 30%, pneumolysin immune complexes occurred in acute-phase serum samples in 16%, and a positive blood culture was found in 20% of the patients. None of the healthy controls had positive results by PCR. The results suggest that the diagnosis of Streptococcus pneumoniae infection from blood samples necessitates the use of several different assays. Pneumolysin PCR was the most sensitive assay, but its clinical value is reduced by the fact that three blood fractions are needed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9986825      PMCID: PMC84500     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Bacterial coinfection in children hospitalized with respiratory syncytial virus infections.

Authors:  M Korppi; M Leinonen; M Koskela; P H Mäkelä; K Launiala
Journal:  Pediatr Infect Dis J       Date:  1989-10       Impact factor: 2.129

2.  C-reactive protein in respiratory virus infections.

Authors:  O Ruuskanen; A Putto; H Sarkkinen; O Meurman; K Irjala
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

3.  Pediatric blood culture evaluation of the BACTEC PEDS Plus and the DuPont Isolator 1.5 systems.

Authors:  K Eisenach; J Dyke; M Boehme; B Johnson; M B Cook
Journal:  Diagn Microbiol Infect Dis       Date:  1992 Mar-Apr       Impact factor: 2.803

4.  Measurement of antibody responses to pneumolysin--a promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia.

Authors:  E Jalonen; J C Paton; M Koskela; Y Kerttula; M Leinonen
Journal:  J Infect       Date:  1989-09       Impact factor: 6.072

5.  Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens.

Authors:  B A Claesson; B Trollfors; I Brolin; M Granström; J Henrichsen; U Jodal; P Juto; I Kallings; K Kanclerski; T Lagergård
Journal:  Pediatr Infect Dis J       Date:  1989-12       Impact factor: 2.129

6.  Detection of Streptococcus pneumoniae in whole blood by PCR.

Authors:  Y Zhang; D J Isaacman; R M Wadowsky; J Rydquist-White; J C Post; G D Ehrlich
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Epidemiology of invasive pneumococcal infections in children in Finland.

Authors:  J Eskola; A K Takala; E Kela; E Pekkanen; R Kalliokoski; M Leinonen
Journal:  JAMA       Date:  1992-12-16       Impact factor: 56.272

8.  Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum.

Authors:  P Salo; A Ortqvist; M Leinonen
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

9.  Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children.

Authors:  H Nohynek; J Eskola; M Kleemola; E Jalonen; P Saikku; M Leinonen
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129

10.  Serologically indicated pneumococcal respiratory infection in children.

Authors:  M Korppi; M Koskela; E Jalonen; M Leinonen
Journal:  Scand J Infect Dis       Date:  1992
View more
  30 in total

1.  Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis.

Authors:  K E Morrison; D Lake; J Crook; G M Carlone; E Ades; R Facklam; J S Sampson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Gram-Positive Pneumonia.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

3.  Using multilocus sequence data to define the pneumococcus.

Authors:  William P Hanage; Tarja Kaijalainen; Elja Herva; Annika Saukkoriipi; Ritva Syrjänen; Brian G Spratt
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

4.  Invasive pneumococcal disease in children up to 5 years of age in Poland.

Authors:  P Grzesiowski; A Skoczynska; P Albrecht; R Konior; M Patrzalek; M Sadowska; J Staroszczyk; L Szenborn; J Wysocki; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 3.267

5.  Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.

Authors:  J Picazo; J Ruiz-Contreras; J Casado-Flores; E Giangaspro; F Del Castillo; T Hernández-Sampelayo; E Otheo; F Balboa; E Ríos; C Méndez
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

6.  PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis.

Authors:  Tomer Avni; Nariman Mansur; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

7.  Broad-range bacterial detection and the analysis of unexplained death and critical illness.

Authors:  Simo Nikkari; Fred A Lopez; Paul W Lepp; Paul R Cieslak; Stephen Ladd-Wilson; Douglas Passaro; Richard Danila; David A Relman
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?

Authors:  E D G McIntosh
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

9.  Competitive inhibition flow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular polysaccharide.

Authors:  H Findlow; G Laher; P Balmer; C Broughton; E D Carrol; R Borrow
Journal:  Clin Vaccine Immunol       Date:  2008-12-17

10.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.